跳至主要内容
临床试验/IRCT20180114038369N1
IRCT20180114038369N1招募中未知

Comparison between the effect of Rosuvastatin and Orlept (Sodium Valproate) in Decrease of migraine headaches

Ghoum University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 70 years(—)
性别
All

入选标准

  • Those who have not received sodium valproate within the last six month.
  • Have migraine headaches With or Without a up to 6 month before this study
  • Confirmation of the presence of migraine by the neurologist
  • There are more than 4 month of attack
  • Have two or more headache attacks over the past 3 month

排除标准

  • Patients with mental illness
  • Patients with systemic and background diseases such as diabetes, liver or malignant diseases
  • Pregnant and Lactating women
  • Desire to quit of this study
  • See incidence of complications

研究者

发起方
Ghoum University of Medical Sciences

相似试验